Vitamin K2 for joints: what the research really shows

Active ton protocole
Woman sitting on the edge of a sofa, hands around her right knee, the joint visible as if on an X-ray with an orange glow

Vitamin K switches on matrix Gla protein, which stops calcium settling in cartilage, and people low in vitamin K develop knee osteoarthritis more often. But the only supplement trial found no overall benefit, and no human trial has tested vitamin K2 for joints. If you take warfarin, never start K2 without your doctor.

The link between vitamin K2 and your joints is plausible, but weaker than the pages selling K2 suggest. Here is what is solid, what is not, and who should not even consider it.

What does vitamin K do in your joints?

Vitamin K is not only about blood clotting. It is the tool that “switches on” a family of proteins, called Gla proteins, by fitting them with a small chemical clamp that can grab calcium. Without vitamin K, these proteins are still made, but they stay inactive.

Clotting factors

Made by the liver. These are what warfarin blocks.

Osteocalcin

Made by bone. It fixes calcium into the bone framework.

Matrix Gla protein

Made by cartilage and arteries. It stops calcium settling in them.

All three depend on the same vitamin. That is why a medicine that blocks vitamin K to thin the blood may also affect cartilage, as you will see below.

The third one matters for joints. Matrix Gla protein, or MGP, is made by chondrocytes, the cells of cartilage. Its role was shown dramatically in 1997: mice bred without MGP calcified their arteries and their cartilage, and died within two months.

Medical render of a golden MGP protein capturing calcium crystals before they settle in the cartilage matrix
In gold, the MGP protein activated by vitamin K; in orange-white, calcium crystals; in blue-grey, the cartilage matrix. Without vitamin K, MGP circulates in an inactive, uncarboxylated form that cannot hold on to calcium.

The hypothesis follows. Cartilage short of active MGP would let calcium settle in it, stiffen and wear faster. Genetics backs it up: a variant of the MGP gene is linked with a higher risk of osteoarthritis. The question is whether this holds in patients, and whether a supplement changes anything.

One distinction before going further. Vitamin K comes in two main forms: K1, from green vegetables, and K2, from fermented foods and animal products. The general roles of K2, in bone and arteries, are covered in our vitamin K2 guide. Here, one question only: your joints.

What do studies in people with osteoarthritis show?

The first study to track osteoarthritis appearing over time followed 1,180 American adults, aged 62 on average, for 30 months. Those who started with a mild vitamin K deficiency, with no symptoms at all, had a 56% higher risk of developing knee osteoarthritis on X-ray. On MRI, their risk of cartilage damage was 2.4 times higher.

Man in his sixties walking down stairs holding the handrail, his right knee visible as if on an X-ray with an orange glow on the cartilage
Going downstairs loads the knee far more than walking on the flat: it is often where knee osteoarthritis makes itself felt first.

The figure is striking, and it needs two caveats. First, these studies measure vitamin K1 in the blood, not K2. They speak to vitamin K status in general, and nothing says K2 does better or worse. Second, an association is not proof. People low in vitamin K often eat fewer vegetables, move less and weigh more, all of which also weigh on the knee, and statistics never fully cancel that out.

The table below ranks the key studies by strength of evidence, from mice to genetics.

StudyWhoResultWhat it proves
Luo, 1997Mice without MGPCalcified cartilage and arteriesMGP holds back calcification of cartilage
Misra, 20131,180 adults followed for 30 monthsVitamin K deficiency: 56% more knee osteoarthritisAn association, not a cause
Neogi, 2008378 adults, 3-year trial, vitamin K1No overall effect on hand osteoarthritisSupplementing everyone does nothing
Boer, 20213,494 adults, including people on vitamin K antagonistsOsteoarthritis 2.5 times more frequent or progressive on these drugsBlocking vitamin K seems to harm cartilage
Zhao, 2022Genetics, up to 826,690 peopleNo causal link between vitamin K levels and osteoarthritisA slightly higher level does not protect

How do you know if you are low in vitamin K?

Not from a standard blood test. Clotting time and INR only change with a frank deficiency, because the liver, which makes the clotting factors, seems to be served first. The mild deficiencies in these studies only show up on research tests: vitamin K1 in plasma, or the inactive form of MGP, which rises when vitamin K runs short.

In practice, the risk shows in your habits more than in a test result: a diet low in green vegetables, a gut condition that interferes with fat absorption, such as coeliac disease or weight-loss surgery, or treatment with warfarin. If that sounds like you, talk to your GP before buying anything.

Warfarin: a natural experiment

Vitamin K antagonists thin the blood by blocking the recycling of vitamin K. In the UK that mostly means warfarin; acenocoumarol and phenindione are used far less. They are meant to target clotting, but nothing stops them from switching off cartilage MGP too. People who take them form, without meaning to, a group deprived of active vitamin K for years.

A team in Rotterdam followed 3,494 participants from a large Dutch cohort, including people taking acenocoumarol, a close relative of warfarin. The result is clear.

Risk of new or worsening osteoarthritis on vitamin K antagonists

Not taking them, reference × 1.0
Taking them, all joints × 2.5
Taking them, knee × 2.3
Taking them, hip × 2.7
Odds ratios from the Rotterdam study (Boer et al., 2021), on X-ray. In users carrying both a risk variant of the MGP gene and high expression of VKORC1, the target of these drugs, the risk rose to 4.2; it did not exist in non-users carrying the same variants.

That last detail matters. If the effect came from the general health of people on these drugs, who are older and more often ill, the MGP gene would play no part. That it only counts in people whose vitamin K is blocked points to a real mechanism.

The authors suggest favouring, where possible, the direct oral anticoagulants, which do not work through vitamin K. Never change your treatment yourself: the choice of anticoagulant depends on your heart, your kidneys and your other medicines, and it is for your GP, cardiologist or anticoagulation clinic to decide.

If you are on warfarin and your knees or hips hurt, mention it at your next review: it is useful information when choosing an anticoagulant. And do not cut green vegetables out of your meals for fear of vitamin K. The rule on warfarin is not avoidance but consistency: roughly the same intake from week to week, the one your dose was set on.

Does vitamin K2 supplementation help your joints?

To date, no published human trial has tested vitamin K2 on osteoarthritis. The only randomised trial available used vitamin K1, in 378 adults followed for 3 years, with one specific measure: how their hands looked on X-ray.

That design shaped the result. The trial was built to study bone and arteries, and its participants were chosen neither for osteoarthritis nor for low vitamin K. Osteoarthritis was assessed afterwards, on hand X-rays.

Result: no overall effect on hand osteoarthritis. A signal appeared only in those who were short of vitamin K at the start and reached a sufficient level: 47% less joint space narrowing, a trend in a small subgroup. Not proof, but a lead consistent with the rest: vitamin K may matter when it is lacking, and add nothing once your needs are met.

Genetics points the same way. A Mendelian randomisation study, which uses the gene variants that set vitamin K levels as a natural lottery, found no cause-and-effect link with osteoarthritis at any joint. Its limit: those variants only shift levels slightly, which says nothing about a real deficiency.

For rheumatoid arthritis, which is an autoimmune disease rather than wear of the cartilage, only small studies exist, and none suggests K2 can stand in for the treatment your rheumatologist prescribes.

The verdict fits in one sentence. Correcting a vitamin K deficiency is sensible and may help cartilage. Taking extra K2 when your intake is already adequate has, on current evidence, no reason to slow established osteoarthritis.

MK-7 or MK-4: which form of vitamin K2?

K2 covers several molecules, the menaquinones, numbered by the length of their side chain. Two dominate supplements: MK-4 and MK-7. They behave very differently once swallowed.

A Japanese team gave healthy women the same dose of each. MK-7 peaked in the blood at 6 hours and was still detectable at 48 hours. MK-4 was not found in the blood of any participant, at any time. After 7 days of low daily doses, only MK-7 had raised blood levels.

Vitamin K1K2, MK-4 formK2, MK-7 form
Where to find itLeafy green vegetablesEgg yolk, meat, butterNatto, mature cheeses
Reaching the bloodThis is the form the osteoarthritis studies measureNot detectable at dietary dosesGood, still present after 48 hours
Official referenceNHS, all vitamin K: about 1 µg per kilo of body weight a dayNoneNone
On warfarinKeep intake steadyAvoid as a supplementAvoid: acts from 10 µg a day

The NHS puts adult needs at about 1 µg of vitamin K per kilo of body weight a day, so around 65 µg for someone weighing 65 kg, and says 1 mg or less a day from supplements is unlikely to cause harm. There is no separate reference for K2: nobody knows how much K2 you would need, or whether you need any beyond K1.

On dose, MK-7 supplements commonly provide 45 µg a day, often more. No dose has been tested, let alone validated, for osteoarthritis: a figure sold “for joints” rests on no trial.

Where to find vitamin K2 in food

Natto, a Japanese fermented soya, outclasses everything: 939 to 998 µg of MK-7 per 100 g. In Europe, mature cheeses are the main source, mostly as MK-9: up to 94 µg per 100 g in some soft cheeses, up to 51 µg in hard cheeses. Egg yolk provides MK-4, from 15 to 64 µg per 100 g depending on the country.

Bowl of sticky natto next to a wedge of mature cheese and an egg yolk on a dark surface
Natto owes its record content to the bacterium that ferments the soya, Bacillus subtilis: microbes, not the original food, make the K2.

Green vegetables provide K1. For joints, K1 is what the observational studies measured: a diet rich in cabbage, spinach, broccoli or salad covers that need without any supplement.

Vitamin K2 and anticoagulants: who should not take it?

This is the point that allows no approximation. If you take warfarin or another vitamin K antagonist, avoid vitamin K2 supplements unless your doctor decides otherwise and checks your INR, the measure of clotting, closely.

The reason is mechanical. Your warfarin dose was set to block a certain amount of vitamin K. Adding more lets clotting recover, your INR falls, and the risk of clot, stroke or embolism comes back. Because MK-7 lingers in the blood for days, its effect builds up gradually, and also takes days to fade. In volunteers on acenocoumarol, 10 µg of MK-7 a day was enough to shift the INR in a clinically relevant way in at least 40% of them, and 20 µg in 60%. At 45 µg, a common shop dose, the average INR fell by about 40%.

Woman of about 70 sitting at her kitchen table, an unlabelled supplement bottle in one hand and a blister pack of tablets in the other
A supplement sold for bones or joints can contain MK-7 without saying so in large print: read the full ingredients list before combining it with warfarin.

The reverse is just as risky. If you were already taking K2 when your warfarin dose was set, stopping it suddenly makes your INR rise and exposes you to bleeding. Either way, the watchword is stability, and any change goes to whoever monitors your INR, often the anticoagulation clinic.

The direct oral anticoagulants, apixaban, rivaroxaban, dabigatran or edoxaban, do not act through vitamin K, and K2 does not compete with them. That is not a green light: on any anticoagulant, check every supplement with your GP or pharmacist first.

Should you take vitamin K2 for your joints?

If you eat few green vegetables and little mature cheese, start with your plate: it is the safest way to cover your vitamin K needs, and it is what the favourable studies measured. A K2 supplement only makes sense if a deficiency is likely, after talking to your GP, and never on warfarin without their agreement.

Supplements often pair K2 with vitamin D3, on the grounds that they work together on calcium. No trial shows that this combination slows osteoarthritis, and vitamin D alone has not been shown to protect cartilage. The pairing has a logic for bone, not yet for joints.

If you still choose one, read the back of the pack. “Vitamin K2” on the front says nothing about the form: look for MK-7 and its dose in micrograms. Check the vitamin D too. The NHS advises 10 µg of vitamin D a day in autumn and winter and no more than 100 µg a day for adults, while some D3 and K2 combinations provide 25 µg or more. That is within the limit, but worth adding up if you take another product containing vitamin D.

For osteoarthritis itself, other levers proved their worth long before K2: NICE puts therapeutic exercise first, with weight loss where it helps and stronger muscles around the joint. We sorted natural remedies for arthritis by the same principle: what works, what does not, what carries risk.

On the inflammatory side of osteoarthritis, our joint and mobility formula for the over-50s combines standardised Longvida curcumin and boswellia. It contains no vitamin K, does not replace exercise or medical advice, and is also not recommended with any anticoagulant.

See a doctor the same day if a joint suddenly turns red, hot and swollen, especially with a fever. On warfarin, report any unusual bleeding or bruising that appears without a knock.

Frequently asked questions

Does vitamin K2 help with joints?

It has never been shown to. Low vitamin K is linked to more knee osteoarthritis, and blocking it with warfarin to more joint damage, but the only supplement trial, using K1 in 378 adults for 3 years, found no overall effect on hand osteoarthritis. Correcting a deficiency may help; extra K2 on top of a good diet has no proven benefit.

Is vitamin K2 good for arthritis?

For osteoarthritis, the evidence stops at associations and one negative trial; no human trial has tested K2 itself. For rheumatoid arthritis, only small studies exist. In neither case is K2 a treatment, and if you take warfarin it can upset your INR, so check with your doctor before trying it.

What happens if I take vitamin K2 every day?

For most people, very little. The NHS says 1 mg or less a day of vitamin K from supplements is unlikely to cause harm, far above the usual 45 µg of MK-7. The real risk is for anyone on warfarin: as little as 10 µg of MK-7 a day can shift the INR.

What drink is high in vitamin K?

No everyday drink is a real source of K2. Green smoothies and juices made with kale, spinach or parsley are rich in K1, the plant form. That is fine for most people, but on warfarin a new daily green smoothie can lower your INR, so keep your intake steady and tell your anticoagulation clinic.


Sources

Luo G., Ducy P., McKee M.D. et al. (1997). Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature, 386(6620), 78-81. DOI: 10.1038/386078a0

Misra D., Booth S.L., Tolstykh I. et al. (2013). Vitamin K deficiency is associated with incident knee osteoarthritis. The American Journal of Medicine, 126(3), 243-248. DOI: 10.1016/j.amjmed.2012.10.011

Neogi T., Felson D.T., Sarno R., Booth S.L. (2008). Vitamin K in hand osteoarthritis: results from a randomised clinical trial. Annals of the Rheumatic Diseases, 67(11), 1570-1573. DOI: 10.1136/ard.2008.094771

Boer C.G., Szilagyi I., Nguyen N.L. et al. (2021). Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis. Annals of the Rheumatic Diseases, 80(5), 598-604. DOI: 10.1136/annrheumdis-2020-219483

Zhao S.S., Bovijn J., Hughes D.M. et al. (2022). Genetically predicted vitamin K levels and risk of osteoarthritis: Mendelian randomization study. Seminars in Arthritis and Rheumatism, 55, 152030. DOI: 10.1016/j.semarthrit.2022.152030

Sato T., Schurgers L.J., Uenishi K. (2012). Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutrition Journal, 11, 93. DOI: 10.1186/1475-2891-11-93

Theuwissen E., Teunissen K.J., Spronk H.M. et al. (2013). Effect of low-dose supplements of menaquinone-7 (vitamin K2) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers. Journal of Thrombosis and Haemostasis, 11(6), 1085-1092. DOI: 10.1111/jth.12203

Walther B., Karl J.P., Booth S.L., Boyaval P. (2013). Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements. Advances in Nutrition, 4(4), 463-473. DOI: 10.3945/an.113.003855

0